The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 22 January 2018 |
| Author/s |
author: Gaël Roué Aránzazu Chamorro Elías Campo |
| Publication date | January 22, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |